145 related articles for article (PubMed ID: 33178938)
1. In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database.
Sato M; Tateishi R; Yasunaga H; Matsui H; Fushimi K; Ikeda H; Yatomi Y; Koike K
BJR Open; 2019; 1(1):20190004. PubMed ID: 33178938
[TBL] [Abstract][Full Text] [Related]
2. Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: A nationwide survey.
Sato M; Tateishi R; Yasunaga H; Matsui H; Horiguchi H; Fushimi K; Koike K
J Gastroenterol Hepatol; 2017 Nov; 32(11):1873-1878. PubMed ID: 28266772
[TBL] [Abstract][Full Text] [Related]
3. Impact of end-stage renal disease on hospital outcomes among patients admitted to intensive care units: A retrospective matched-pair cohort study.
Iwagami M; Yasunaga H; Matsui H; Horiguchi H; Fushimi K; Noiri E; Nangaku M; Doi K
Nephrology (Carlton); 2017 Aug; 22(8):617-623. PubMed ID: 27248702
[TBL] [Abstract][Full Text] [Related]
4. In-Hospital Mortality in Cirrhotic Patients with End-Stage Renal Disease Treated with Hemodialysis Versus Peritoneal Dialysis: A Nationwide Study.
Nader MA; Aguilar R; Sharma P; Krishnamoorthy P; Serban D; Gordon-Cappitelli J; Shen W; Nilubol C; Li P; Lipkowitz M
Perit Dial Int; 2017; 37(4):464-471. PubMed ID: 28348101
[TBL] [Abstract][Full Text] [Related]
5. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.
Cohen MJ; Bloom AI; Barak O; Klimov A; Nesher T; Shouval D; Levi I; Shibolet O
World J Gastroenterol; 2013 Apr; 19(16):2521-8. PubMed ID: 23674854
[TBL] [Abstract][Full Text] [Related]
6. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
9. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy.
Zhang CW; Dou CW; Zhang XL; Liu XQ; Huang DS; Hu ZM; Liu J
World J Gastroenterol; 2020 Aug; 26(30):4489-4500. PubMed ID: 32874060
[TBL] [Abstract][Full Text] [Related]
11. Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.
Lee TY; Lin CC; Chen CY; Wang TE; Lo GH; Chang CS; Chao Y
Medicine (Baltimore); 2017 Sep; 96(37):e7655. PubMed ID: 28906355
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for the development of pulmonary oil embolism after transcatheter arterial chemoembolization of hepatic tumors.
Wu GC; Chan ED; Chou YC; Yu CY; Hsieh TY; Hsieh CB; Chian CF; Ke FC; Dai YL; Su WL
Anticancer Drugs; 2014 Sep; 25(8):976-81. PubMed ID: 24736105
[TBL] [Abstract][Full Text] [Related]
13. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.
Sato M; Tateishi R; Yasunaga H; Horiguchi H; Yoshida H; Matsuda S; Koike K
J Gastroenterol; 2012 Oct; 47(10):1125-33. PubMed ID: 22426637
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
[TBL] [Abstract][Full Text] [Related]
15. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
Li L; Tian J; Liu P; Wang X; Zhu Z
Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
[TBL] [Abstract][Full Text] [Related]
17. Increased Rate of Intermediate-Term Valve Failure After TAVR in End-Stage Renal Disease Patients Requiring Maintenance Dialysis.
Long A; Mahoney P
J Invasive Cardiol; 2019 Oct; 31(10):307-313. PubMed ID: 31567115
[TBL] [Abstract][Full Text] [Related]
18. A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao S; Zhang T; Dou W; Wang E; Wang M; Wang C; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):542. PubMed ID: 32411765
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
Huang YK; Yen CL; Shiu SI; Lee SW; Chang PY; Yeh HZ; Lee TY
PLoS One; 2017; 12(11):e0188999. PubMed ID: 29190692
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
